Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Necator americanus Inoculation in Celiac Disease
NCT00671138Phase 2Completed
- Sponsor
- Princess Alexandra Hospital
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in celiac disease comparing Hookworm with Placebo (2 arms). Primary endpoints: Duodenal histology (Marsh classification) at 21 weeks and Rectal histology at 21 weeks. Started Oct 2007; status: completed.
02
Drugs
Necator americanus larvae
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT00671138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671138.